200
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs

, , &
Pages 1245-1251 | Published online: 20 Jun 2011

References

  • SudhakarYKuotsuKBandyopadhyayAKBuccal bioadhesive drug delivery – a promising option for orally less efficient drugsJ Control Release20061141154016828915
  • PatherSIRathboneMJSenelSCurrent status and the future of buccal drug delivery systemsExpert Opin Drug Deliv20085653154218491980
  • WaltonRPSublingual administration of drugsJ Am Med Assoc19441243138143
  • BickelMHWederHJBuccal absorption and other properties of pharmacokinetic importance of imipramine and its metabolitesJ Pharm Pharmacol19692131601684388211
  • LipinskiCPoor aqueous solubility – an industry wide problem in drug discoveryAm Pharm Rev200258285
  • HengstmannJHGoronzyJPharmacokinetics of 3H-phenylephrine in manEur J Clin Pharmacol19822143353417056280
  • KanferIDowseRVumaVPharmacokinetics of oral decongestantsPharmacotherapy1993136 Pt 2S116S128S143S146
  • KileDEChiouCTWater solubility enhancements of DDT and trichlorobenzene by some surfactants below and above the critical micelle concentrationEnviron Sci Technol1989237832838
  • BalakrishnanARegeBDAmidonGLPolliJESurfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivityJ Pharm Sci20049382064207515236455
  • BetageriGVMakarlaKREnhancement of dissolution of glyburide by solid dispersion and lyophilization techniquesInt J Pharm19951261–2155160
  • JungJYYooSDLeeSHKimKHYoonDSLeeKHEnhanced solubility and dissolution rate of itraconazole by a solid dispersion techniqueInt J Pharm1999187220921810502627
  • VerhoefJCSchipperNGMRomeijnSGMerkusFWHMThe potential of cyclodextrins as absorption enhancers in nasal delivery of peptide drugsJ Control Release1994293351360
  • JugMBecirevic LacanMInfluence of hydroxypropyl-[beta]-cyclodextrin complexation on piroxicam release from buccoadhesive tabletsEur J Pharm Sci2004212–325126014757497
  • FigueirasACarvalhoRARibeiroLTorres LabandeiraJJVeigaFJBSolid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified [beta]-cyclodextrinEur J Pharm Biopharm200767253153917451924
  • FigueirasAHombachJVeigaFBernkop SchnürchAIn vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole deliveryEur J Pharm Biopharm200971233934518796330
  • MüllerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
  • LiversidgeGCDrug nanocrystals for improved drug deliveryThe 23rd International Symposium of Controlled Release Bioactive Materials, Workshop on Particulate Drug Delivery Systems, Kyoto, JapanJul 7–10Kyoto, Japan19967481
  • MüllerRHNanosuspensionen-eine neue formulierung für schwerlösliche arzneistoffeMüllerRHHildebrandGEPharmazeutische Technologie: Moderne Arzneiformen, Lehrbuch für Studierende der Pharmazie-Nachschlagewerk für Apotheker in Offizin, Krankenhaus und ForschungStuttgartWissenschaftliche1998393399
  • MüllerRHJacobsCBuparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stabilityInt J Pharm20022371–215116111955813
  • JacobsCKayserOMüllerRHProduction and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquoneInt J Pharm20012141–23711282227
  • MishraPRShaalLAMüllerRHKeckCMProduction and characterization of Hesperetin nanosuspensions for dermal deliveryInt J Pharm20093711–218218919162147
  • PignatelloRBucoloCFerraraPMalteseAPuleoAPuglisiGEudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofenEur J Pharm Sci2002161–2536112113891
  • KleemannENeuMJekelNNano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEIJ Control Release20051091–329931616298009
  • MüllerRHBöhmBHLNanosuspensionsMüllerRHBenitaSBöhmBEmulsions and Nanosuspensions for the Formulation of Poorly Soluble DrugsStuttgartMedpharm Scientific1998143147
  • MüllerRHBöhmBHLNanosuspensionsMüllerRHBenitaSBöhmBEmulsions and Nanosuspensions for the Formulation of Poorly Soluble DrugsStuttgartMedpharm Scientific1998149173
  • MosharrafMNyströmCThe effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInt J Pharm19951221–23547
  • NystromCDissolution properties of soluble drugs: theoretical background and possibilities to improve the dissolution behaviorMullerRHBenitaSBohmBEmulsions and Nanosuspensions for the Formulation of Poorly Soluble DrugsStuttgartMedpharm Scientific1998143147
  • NagaiTMachidaYKonishiRBioadhesive dosage forms for buccal/gingival administrationLenaertsVGurnyRBioadhesive Drug Delivery SystemsFloridaCRC Press, Inc.1990137152
  • GuoJHCremerKDevelopment of bioadhesive buccal patchesMathiowitzEIIIDECLehrC-MBioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and DevelopmentNew YorkMarcel Dekker, Inc1999541562
  • RaoSSongYPeddieFEvansAA novel tri-layered buccal mucoadhesive patch for drug delivery: assessment of nicotine deliveryJ Pharm Pharmacol2011 In press.
  • KesisoglouFPanmaiSWuYNanosizing – oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev200759763164417601629
  • Diaz del ConsueloIFalsonFGuyRHJacquesYEx vivo evaluation of bioadhesive films for buccal delivery of fentanylJ Control Release2007122213514017688966
  • PatelVMPrajapatiBGPatelJKPatelMMPhysicochemical characterization and evaluation of buccal adhesive patches containing propranolol hydrochlorideCurr Drug Deliv20063332533116848734